2
Views
5
CrossRef citations to date
0
Altmetric
Original Article

The Characterization of β Adrenoceptor Subtypes in the Rat Amygdala and Hippocampus

&
Pages 231-244 | Received 08 Apr 1990, Published online: 07 Jul 2009
 

Abstract

(-)-[125I]Iodocyanopindolol ((-)ICYP), is a ligand with high specific activity and nearly equal affinity for β1, and β2, adrenoceptors in a variety of tissues. Unfortunately, (-)ICYP also has affinity for 5HT1B serotonin receptors. To get an accurate estimate of β adrenoceptors in the rat amygdala and hippocampus, (-)ICYP binding studies were done with membranes from these limbic structures in the presence of 10μM serotonin to prevent the binding of (-)ICYP to serotonin receptors. Under these conditions, (-)ICYP binding to amygdaloid and hippocampus membrane preparations is saturable and reversible. Scatchard analyses revealed in both regions a single class of binding sites with an equilibrium dissociation constant (KD) of 18.5 pM for the amygdala and 19.6 pM for the hippocampus. The hippocampus has a significantly lower density of binding sites (Bmax) than amygdala (51.6 vs 62.3 fmol/mg membrane protein, p <. 05). The two brain regions do not differ with respect to kinetic reactions in that both show comparable slow association and dissociation rates. However, the dissociation reactions do reveal two affinity states for the binding sites in both areas. Detailed competition analyses with β adrenoceptor subtype selective drugs (ICI-89406 and ICI-118551) show that in both regions about 70% of the β adrenoceptor population is of the β1, subtype with the remainder being β2 subtype.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.